PORTOLA VALLEY, Calif.–(BUSINESS WIRE)–TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of Directors. “Dr. Simpson’s remarkable history of clinical excellence, innovation, scientific achievement, and entrepreneurial expertise immediately expands TransMed7’s strategic options for rapid development and deployment of […]
Author: Ken Dropiewski
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)
BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share dividend. Q2 2018 Results Record sales of $27.0mm, +5% vs. Q2 2017 Record operating income of $11.5mm vs. $5.5mm, +108% Record net income […]
Zynex Schedules 2018 Second Quarter Earnings Release and Webcast
LONE TREE, Colo., July 27, 2018 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2018 second quarter investor webcast on Thursday, August 2, 2018 at 11:00 […]
Edwards Lifesciences Reports Second Quarter Results
IRVINE, Calif., July 26, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2018. Second Quarter and Recent Highlights: Sales grew 12 percent; underlying1 sales grew 10 percent Global THVT sales grew […]
Slidell Memorial Hospital Installs Canon Medical’s Infinix-i Dual Plane to Support Advanced Coronary and Peripheral Vascular Interventional Procedures
TUSTIN, Calif.–(BUSINESS WIRE)–Clinicians at Slidell Memorial Hospital in Slidell, Louisiana now have access to advanced diagnostic imaging to help them maximize flexibility, minimize exposure and optimize image quality during interventional procedures thanks to the recent installation of Canon Medical’s InfinixTM-i Dual-Plane system. Slidell Memorial Hospital is using the Infinix-i Dual-Plane for a variety […]
Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated
DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, announced the Impella 2.5®, Impella CP® and Impella 5.0® heart pumps received Central Drugs Standard Control Organization (CDSCO) approval in India for use during high-risk percutaneous coronary intervention (PCI), cardiogenic shock, and […]
Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) — ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2019 revenue of $180.0 million, an increase of 36% compared to revenue of $132.5 million for the same period of fiscal 2018. First quarter fiscal 2019 […]
REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ bioresorbable scaffold is the first drug-eluting bioresorbable scaffold to receive CE Mark approval for treatment of below the knee peripheral […]
BioTelemetry, Inc. Reports Second Quarter 2018 Financial Results
MALVERN, Pa., July 25, 2018 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2018. Quarter Highlights Recognized highest […]
CryoLife to Present at 38th Annual Canaccord Genuity Growth Conference
ATLANTA, July 26, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 38th Annual Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at the InterContinental Boston Hotel. A live webcast of the Company’s presentation is scheduled to begin at 11:30 […]



